Objective The prevalence of symptomatic coeliac disease in Norway is 1 : 675.
Coeliac disease has previously been reported in presumably healthy people.
Our aim was to determine the prevalence of latent coeliac disease in apparently healthy (i.e. asymptomatic) Norwegian individuals.
Methods Blood donor sera were tested for gluten antibodies (IgA, lgG).
Positive samples (IgA AGA>0.35, IgG AGA>0.90) were further tested for endomysium antibodies (IgA EMA).
EMA positive individuals were offered gastroenterological investigation.
Results Of 2096 sera, 83 fulfilled the criteria for EMA testing (M/F=55/28).
Eight individuals were EMA positive.
On biopsy, seven out of eight had villous atrophy (six subtotal, one partial).
None of the patients had significant symptoms.
Biochemical data showed iron deficiency (two), hypocalcaemia (one), and low serum zinc (five).
All patients were treated with a gluten-free diet and followed up.
Conclusion The study indicates a prevalence of 1 : 340 among asymptomatic and presumably healthy people.
This is in keeping with studies from other countries.
Lack of symptoms does not exclude secondary deficiency conditions.
Mots-clés Pascal : Coeliaque maladie, Asymptomatique, Prévalence, Donneur sang, Dépistage, Homme, Norvège, Europe, Résultat, Appareil digestif pathologie, Intestin pathologie, Malabsorption intestinale, Immunopathologie, Prévention
Mots-clés Pascal anglais : Coeliac disease, Asymptomatic, Prevalence, Blood donor, Medical screening, Human, Norway, Europe, Result, Digestive diseases, Intestinal disease, Intestinal malabsorption, Immunopathology, Prevention
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0168349
Code Inist : 002B13B03. Création : 16/11/1999.